2C-iBu

2C-iBu
Clinical data
Other names4-Isobutyl-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-isobutylphenethylamine; 2C-iBu; 2C-IB; ELE-02; ELE02; ELEU02
Routes of
administration		Oral, ophthalmic
Drug classSerotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen; Anti-inflammatory drug
Pharmacokinetic data
Protein binding74%
Duration of action20 hours
Identifiers
  • 2-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]ethanamine
PubChem CID
Chemical and physical data
FormulaC14H23NO2
Molar mass237.343 g·mol−1
3D model (JSmol)
  • CC(C)CC1=C(C=C(C(=C1)OC)CCN)OC
  • InChI=1S/C14H23NO2/c1-10(2)7-12-9-13(16-3)11(5-6-15)8-14(12)17-4/h8-10H,5-7,15H2,1-4H3
  • Key:FLBABUVVTQBINW-UHFFFAOYSA-N

2C-iBu, or 2C-IB, also known as 4-isobutyl-2,5-dimethoxyphenethylamine or by its developmental code name ELE-02, is a serotonin 5-HT2A receptor agonist, serotonergic psychedelic, and anti-inflammatory drug which is under development for the treatment of inflammation. It is a member of the phenethylamine and 2C families of compounds. The drug is being developed as a topical eye drop for treatment of inflammatory eye conditions. There is also interest in 2C-iBu and related drugs for treatment of systemic inflammation and neuroinflammation.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.